Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters










Publication year range
1.
Appl Mater Today ; 32: 101833, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37152683

ABSTRACT

Face masks have proven to be a useful protection from airborne viruses and bacteria, especially in the recent years pandemic outbreak when they effectively lowered the risk of infection from Coronavirus disease (COVID-19) or Omicron variants, being recognized as one of the main protective measures adopted by the World Health Organization (WHO). The need for improving the filtering efficiency performance to prevent penetration of fine particulate matter (PM), which can be potential bacteria or virus carriers, has led the research into developing new methods and techniques for face mask fabrication. In this perspective, Electrospinning has shown to be the most efficient technique to get either synthetic or natural polymers-based fibers with size down to the nanoscale providing remarkable performance in terms of both particle filtration and breathability. The aim of this Review is to give further insight into the implementation of electrospun nanofibers for the realization of the next generation of face masks, with functionalized membranes via addiction of active material to the polymer solutions that can give optimal features about antibacterial, antiviral, self-sterilization, and electrical energy storage capabilities. Furthermore, the recent advances regarding the use of renewable materials and green solvent strategies to improve the sustainability of electrospun membranes and to fabricate eco-friendly filters are here discussed, especially in view of the large-scale nanofiber production where traditional membrane manufacturing may result in a high environmental and health risk.

2.
J Phys Chem B ; 125(9): 2380-2388, 2021 Mar 11.
Article in English | MEDLINE | ID: mdl-33625218

ABSTRACT

The intra- and intermolecular interactions in ether-functionalized ionic liquids (ILs) are studied by means of infrared (IR) spectroscopy measurements of N-ethoxyethyl-N-methylpiperidiniumbis(fluorosulfonyl)imide (P1,2O2-FSI) and N-ethoxyethyl-N-methylmorpholiniumbis(fluorosulfonyl)imide (M1,2O2-FSI). The temperature dependence of the spectra in the medium IR range allows the study of the anion conformer distribution and its variation during phase transitions. In particular, it is found that for both ILs the trans conformer of FSI is more stable than the cis conformer, and the enthalpy differences between them are calculated and are found to decrease upon the addition of a Li salt. The results obtained in the far IR range, combined with ab initio calculation of the ionic couple performed using the B3LYP-D functional and considering both empirical dispersion corrections and the presence of a polar solvent, provide evidence for the occurrence of a hydrogen bonding between the O atom of the anion and its closest H atoms directly linked to a C atom of the cation. The comparison with samples having the same cations but with bis(trifluoromethanesulfonyl)imide (TFSI) as an anion, that is, M1,2O2-TFSI and P1,2O2-TFSI, as well as with samples having cations without the ether-functionalization neither in the ring nor in the side chain, such as N-propyl-N-methylpyrrolidinium-FSI (PYR13-FSI) and 1-butyl-1-methylpyrrolidinium-TFSI (PYR14-TFSI), indicates that the occurrence of such highly directional interaction between anion and cation is better observable in the ether-functionalized samples, in particular in those containing FSI as an anion.

3.
Phys Chem Chem Phys ; 22(14): 7497-7506, 2020 Apr 08.
Article in English | MEDLINE | ID: mdl-32219245

ABSTRACT

The temperature dependence of the far- and mid-infrared spectrum of two prototypical protic ionic liquids (PILs) sharing a common trialkylammonium cation, but having different anions, is investigated. The exploitation of both the FIR and MIR ranges provides complementary information about the microscopic configurations and the intermolecular interactions, which determine the structure and the properties of ILs. The analysis of the data collected for all the measured frequencies in a wide temperature range reveals several phase transitions and allows the evaluation of the conformer distribution in the different physical states. The difference in the average energy between the H-bonded configurations and the dispersion-governed ones was also determined for the two PILs. Moreover, a computational model for ionic couples based on the ωB97X-D functional and a polar solvent is here successfully exploited for the description of the hydrogen bonding between anion and cation. For the attribution of vibrational lines of the conformers of the cation, the picture based on single ion calculations at the B3LYP level is more valuable and provides better agreement with the experiments.

4.
Nanomedicine (Lond) ; 13(24): 3091-3106, 2018 12.
Article in English | MEDLINE | ID: mdl-30451074

ABSTRACT

AIM: The aim of this work is the dissection of the molecular pathways underlying the differentiation effect of reduced graphene oxide (GO) materials in the absence of differentiation agents. MATERIALS & METHODS: Reduced GO is obtained either by drop casting method and heat-treated or biological reduction by the interaction between GO and wtPrxI. Cells were grown on both materials and the differentiation process studied by immunological and morphological detection. RESULTS & CONCLUSION: The results obtained indicate that both reduction methods of GO can determine the modulation of pathway involved in mechano-transduction and differentiation, by affecting YAP/TAZ localization outside the nuclei and increasing neuronal differentiation markers. This suggests that the mechano-transduction pathways are responsible for the differentiation process.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Graphite/metabolism , Mechanotransduction, Cellular/physiology , Neurons/metabolism , Phosphoproteins/metabolism , Transcription Factors/metabolism , Acyltransferases , Cell Differentiation , Cell Line , Humans , Neurons/cytology , Oxidation-Reduction , Signal Transduction , Surface Properties , YAP-Signaling Proteins
5.
J Mol Neurosci ; 65(3): 385-390, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29974380

ABSTRACT

Increasing evidence suggests that uric acid (UA) is a relevant risk factor for arteriolosclerosis and recent studies have demonstrated the positive relationship between UA concentrations and the severity of leukoaraiosis. However, the association between lacunar infarcts (LI) and UA levels has seldom been reported in the literature. The aim of our study was to assess whether serum UA levels may be related to the presence of LI. We recruited 242 patients (113 males and 129 females, aged 82.83 ± 6.49 years) from our Geriatric Department for whom CAT scans (CT) were available. Clinical and laboratory data was collected. Patients CT images were examined to identify the presence, the size, the number, and the location of LI. LI without neurological symptoms were considered silent LI. Serum UA levels were found to be positively associated with the presence (p = 0.0001), the number (p = 0.001), the size (p = 0.001), and the location of LI in the basal ganglia (p = 0.0038), the deep white matter (DWM) (p < 0.0001), and the pons (p = 0.0156). A significant association was also found between UA and silent LI (p = 0.0002). The prevalence of LI increased starting from UA levels of 5.7 mg/dl. Stepwise multiple regression analysis confirmed that UA was independently related with the presence, the number, the size, LI in the basal ganglia, the DWM, the pons, and with silent LI. Our study suggests a positive association between UA levels and LI, which is independent of traditional cardiovascular risk factors. This data suggests that UA plays an influential role on the physiopathology of LI and could represent a potential target to prevent cerebral microinfarcts.


Subject(s)
Stroke, Lacunar/blood , Uric Acid/blood , Aged , Aged, 80 and over , Biomarkers/blood , Female , Humans , Male , Stroke, Lacunar/diagnostic imaging , Stroke, Lacunar/pathology
6.
Biochem Pharmacol ; 154: 303-317, 2018 08.
Article in English | MEDLINE | ID: mdl-29803506

ABSTRACT

Neurodegenerative diseases (NDs) and brain tumors are severe, disabling, and incurable disorders that represent a critical problem regarding human suffering and the economic burden on the healthcare system. Because of the lack of effective therapies to treat NDs and brain tumors, the challenge for physicians is to discover new drugs to improve their patients' quality of life. In addition to risk factors such as genetics and environmental influences, increased cellular oxidative stress has been reported as one of the potential common etiologies in both disorders. Given their antioxidant and anti-inflammatory potential, dietary polyphenols are considered to be one of the most bioactive natural agents in chronic disease prevention and treatment. Despite the protective activity of polyphenols, their inefficient delivery systems and poor bioavailability strongly limit their use in medicine and functional food. A potential solution lies in polymeric nanoparticle-based polyphenol delivery systems that are able to enhance their absorption across the gastrointestinal tract, improve their bioavailability, and transport them to target organs. In the present manuscript, we provide an overview of the primary polyphenols used for ND and brain tumor prevention and treatment by focusing on recent findings, the principal factors limiting their application in clinical practice, and a promising delivery strategy to improve their bioavailability.


Subject(s)
Brain Neoplasms/prevention & control , Drug Delivery Systems/methods , Nanoparticles/administration & dosage , Neurodegenerative Diseases/prevention & control , Phytochemicals/administration & dosage , Polyphenols/administration & dosage , Animals , Antioxidants/administration & dosage , Antioxidants/chemistry , Antioxidants/metabolism , Brain Neoplasms/metabolism , Clinical Trials as Topic/methods , Humans , Nanoparticles/chemistry , Nanoparticles/metabolism , Neurodegenerative Diseases/metabolism , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/chemistry , Neuroprotective Agents/metabolism , Phytochemicals/chemistry , Phytochemicals/metabolism , Polyphenols/chemistry , Polyphenols/metabolism
7.
Cancer Lett ; 412: 272-282, 2018 01 01.
Article in English | MEDLINE | ID: mdl-29111347

ABSTRACT

NPM1 is a multifunctional nucleolar protein implicated in several processes such as ribosome maturation and export, DNA damage response and apoptotic response to stress stimuli. The NPM1 gene is involved in human tumorigenesis and is found mutated in one third of acute myeloid leukemia patients, leading to the aberrant cytoplasmic localization of NPM1. Recent studies indicated that the N6L multivalent pseudopeptide, a synthetic ligand of cell-surface nucleolin, is also able to bind NPM1 with high affinity. N6L inhibits cell growth with different mechanisms and represents a good candidate as a novel anticancer drug for a number of malignancies of different histological origin. In this study we investigated whether N6L treatment could drive antitumor effect in acute myeloid leukemia cell lines. We found that N6L binds NPM1 at the N-terminal domain, co-localizes with cytoplasmic, mutated NPM1, and interferes with its protein-protein associations. N6L toxicity appears to be p53 dependent but interestingly, the leukemic cell line harbouring the mutated form of NPM1 is more resistant to treatment, suggesting that NPM1 cytoplasmic delocalization confers protection from p53 activation. Moreover, we show that N6L sensitizes AML cells to doxorubicin and cytarabine treatment. These studies suggest that N6L may be a promising option in combination therapies for acute myeloid leukemia treatment.


Subject(s)
Leukemia, Myeloid, Acute/drug therapy , Nuclear Proteins/physiology , Peptides/pharmacology , Cell Line, Tumor , Cytarabine/pharmacology , Doxorubicin/pharmacology , Humans , Mutation , Nuclear Proteins/analysis , Nuclear Proteins/genetics , Nucleophosmin , Tumor Suppressor Protein p53/physiology
8.
Curr Alzheimer Res ; 15(4): 336-344, 2018 02 22.
Article in English | MEDLINE | ID: mdl-28521669

ABSTRACT

BACKGROUND: PPARs are lipid sensors activated by dietary lipids or their metabolites, mainly fatty acids and eicosanoids, that play critical roles in CNS biology, since brain has a very high lipid content and has the higher energetic metabolism in the body. METHODS: In neurodegenerative diseases in addition to metabolic impairment, also neuroinflammation is observed and PPARs are also closely linked to inflammatory processes. Several studies have revealed a complicated relationship between the innate immune response and tissue metabolism. RESULTS: In the brain, during pathological conditions, an alteration in metabolic status occurs, particularly involving glucose utilization and production, a condition which is generally related to metabolic changes. CONCLUSION: Taking into account the high expression of PPARs in the brain, this review will focus on the role of these transcription factors in CNS diseases.


Subject(s)
Brain/metabolism , Inflammation/metabolism , Neurodegenerative Diseases/metabolism , Peroxisome Proliferator-Activated Receptors/metabolism , Animals , Humans , Inflammation/pathology
9.
Cell Cycle ; 16(1): 59-72, 2017 Jan 02.
Article in English | MEDLINE | ID: mdl-27860527

ABSTRACT

PPARs are a class of ligand-activated transcription factors belonging to the superfamily of receptors for steroid and thyroid hormones, retinoids and vitamin D that control the expression of a large number of genes involved in lipid and carbohydrate metabolism and in the regulation of cell proliferation, differentiation and death. The role of PPARs in the CNS has been primarily associated with lipid and glucose metabolism; however, these receptors are also implicated in neural cell differentiation and death, as well as neuronal maturation. Although it has been demonstrated that PPARs play important roles in determining NSCs fate, less is known about their function in regulating NSCs metabolism during differentiation. In order to identify the metabolic events, controlled by PPARs, occurring during neuronal precursor differentiation, the glucose and lipid metabolism was followed in a recognized model of neuronal differentiation in vitro, the SH-SY5Y neuroblastoma cell line. Moreover, PPARs distribution were also followed in situ in adult mouse brains. The concept of adult neurogenesis becomes relevant especially in view of those disorders in which a loss of neurons is described, such as Alzheimer disease, Parkinson disease, brain injuries and other neurological disorders. Elucidating the crucial steps in energetic metabolism and the involvement of PPARγ in NSC neuronal fate (lineage) may be useful for the future design of preventive and/or therapeutic interventions.


Subject(s)
Aging/metabolism , Energy Metabolism , Neurogenesis , Peroxisome Proliferator-Activated Receptors/metabolism , Animals , Body Patterning , Boron Compounds/metabolism , Brain/metabolism , Cell Differentiation , Cell Line, Tumor , Gene Silencing , Glial Fibrillary Acidic Protein/metabolism , Glycogen/metabolism , Humans , Male , Mice, Inbred C57BL , Nestin/metabolism , RNA, Small Interfering/metabolism , beta Catenin/metabolism
10.
J Neurosurg Sci ; 56(3): 239-45, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22854592

ABSTRACT

AIM: Approximate survival for glioblastoma is less than 1 year. Age, histological features and performance status at presentation represent the three statistically independent factors affecting longevity. The purpose of the study was to assess the role of surgery and to analyze prognostic factors in our patients operated for glioblastoma. METHODS: We evaluated in 56 patients operated for glioblastoma their depressive and performance status in the preoperative and postoperative time. Moreover we analyzed the extent of surgery, the site and the size of lesions. RESULTS: Median overall survival was 17 months. An age of ≥60 years (P<0.03), a preoperative Karnofsky Performance Status KPS≤70 (P=0.04), a subtotal tumor resection (P<0.001), a tumor size >5 cm (P=0.01), and no postoperative adjuvant treatment (P=0.01) were associated with the worst prognosis. Before surgery we found the presence of depression in 10 patients with a significative reduction of mean Back Depression Inventory scores after tumor resection (P=0.03). Finally, a KPS≤70 was significantly associated with an increased incidence of depression in the postoperative time. CONCLUSION: Tumor size, total resection and affective disorders were identified as predictors of survival in our series of patients with glioblastoma in addition to age and KPS score. In our opinion an early diagnosis and the use of specific safeguards in the operating room contribute to have an extension of the tumor progression time and median survival.


Subject(s)
Brain Neoplasms/mortality , Brain Neoplasms/surgery , Glioblastoma/mortality , Glioblastoma/surgery , Adult , Aged , Aged, 80 and over , Brain Neoplasms/psychology , Depressive Disorder/diagnosis , Depressive Disorder/mortality , Female , Glioblastoma/psychology , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Postoperative Complications/mortality , Postoperative Complications/psychology , Prognosis , Quality of Life/psychology , Risk Factors , Survivors/psychology , Survivors/statistics & numerical data
11.
J Cell Physiol ; 227(3): 939-51, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21503892

ABSTRACT

Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults, with a median survival of ~12-18 months post-diagnosis. GBM usually recurs within 12 months post-resection, with poor prognosis. Thus, novel therapeutic strategies to target and kill GBM cells are urgently needed. The marked difference of tumour cells with respect to normal brain cells renders glioblastoma a good candidate for selective targeted therapies. Recent experimental strategies focus on over expressed cell surface receptors. Targeted toxins represent a new class of selective molecules composed by a potent protein toxin and a carrier ligand. Targeted toxins approaches against glioblastoma were under investigation in phase I and II clinical trials with several immunotoxins (IT)/ligand toxins such as IL4-Pseudomonas aeruginosa exotoxin A (IL4-PE, NBI-3001), tumour growth factor fused to PE38, a shorter PE variant, (TGF)alpha-TP-38, IL13-PE38, and a transferrin-C diphtheriae toxin mutant (Tf-CRM107). In this work, we studied the effects of the plant ribosome-inactivating saporin and of its chimera transferrin-saporin against two different GBM cell lines. The data obtained here indicate that cell proliferation is affected by the toxin treatments but that different mechanisms are used, directly linked to the presence of an active or inactive p53. A model is proposed for these alternative intracellular pathways.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Brain Neoplasms/drug therapy , Glioblastoma/drug therapy , Ribosome Inactivating Proteins, Type 1/toxicity , Transferrin/toxicity , Apoptosis/drug effects , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Line, Tumor , Clinical Trials as Topic/methods , Drug Design , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Nanoconjugates/toxicity , Ribosome Inactivating Proteins, Type 1/genetics , Saporins , Transferrin/genetics , Tumor Suppressor Protein p53/metabolism
12.
J Cell Biochem ; 113(2): 571-9, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21938743

ABSTRACT

Nucleolin is a multifunctional DNA and RNA binding protein involved in regulation of gene transcription, chromatin remodeling, RNA metabolism, and ribosomal RNA synthesis. Nucleolin seems to be over-expressed in highly proliferative cells and is involved in many aspect of gene expression: DNA recombination and replication, RNA transcription by RNA polymerase I and II, rRNA processing, mRNA stabilization, cytokinesis, and apoptosis. Although nucleolin is localized predominantly in the nucleolus, it has also been shown to be localized in a phosphorylated/glycolsilated form on the cell surface of different cells. Numerous articles dealing with surface nucleolin targeting for tumor therapy have been recently published. However, at present, no extensive informations are so far available for the presence of nucleolin in human gliomas. In the present work we investigated on the presence and localization of nucleolin in glioma on glioma specimens at different grade of malignancy and on primary glioma cell cultures derived by surgical resection, trying to correlate the presence of glycosilated membrane nucleolin with the malignancy grade. To this purpose an antibody produced by us against gp273 protein, demonstrated to recognized the glycosilated surface nucleolin, has been used. The results obtained demonstrate that surface nucleolin increase with the malignancy grade thus suggesting that it may constitute a histopathological marker for glioma grading and a possible tool for targeted therapy.


Subject(s)
Astrocytoma/metabolism , Biomarkers, Tumor/metabolism , Brain Neoplasms/metabolism , Phosphoproteins/metabolism , Protein Processing, Post-Translational , RNA-Binding Proteins/metabolism , AC133 Antigen , Aged , Antigens, CD/metabolism , Astrocytoma/pathology , Brain Neoplasms/pathology , Cells, Cultured , Glial Fibrillary Acidic Protein/metabolism , Glycoproteins/metabolism , Glycosylation , Humans , Middle Aged , Neoplasm Grading , Neoplastic Stem Cells/metabolism , Peptides/metabolism , Protein Transport , SOXB1 Transcription Factors/metabolism , Nucleolin
13.
J Cell Biochem ; 112(12): 3891-901, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21866563

ABSTRACT

Glioblastoma multiforme (GBM) represents the most severe type of glioma, the most common brain tumor. Their malignancy shows a relationship with an increased proliferation and a poorly organized tumor vascularization, an event that leads to inadequate blood supply, hypoxic areas and at last to the formation of necrotic areas, a feature of glioblastoma. Hypoxic/necrotic tumors are more resistant to chemotherapy and radiation therapies, thus it is crucial to formulate new therapeutic approaches that can render these tumors more sensitive to the action of conventional therapies. It has been demonstrated that under hypoxia, gliomas accumulate lipid droplets and that this event is positively correlated with the degree of malignancy, glioblastoma being the most endowed with lipid droplets. We have previously demonstrated in ex vivo glioma specimens a grade-dependent lipid metabolism perturbation. Here we studied the lipid pathways and the presence of stemness markers in glioma primary cultures, obtained from surgical specimens of patients affected by glioma at different grade of malignancy, GBM primary cultures cultured under both hypoxic and normoxic conditions, as well as normal human astrocytes. The results obtained demonstrate that hypoxia plays a crucial role in regulating the expression of lipid metabolism peroxisomal enzymes, the lipid droplets accumulation as well as the transcription factor PPARα.


Subject(s)
Brain Neoplasms/metabolism , Glioblastoma/metabolism , Lipid Metabolism , PPAR gamma/metabolism , Peroxisomes/enzymology , Brain Neoplasms/pathology , Cell Line, Tumor , Glioblastoma/pathology , Humans
14.
Int J Immunopathol Pharmacol ; 24(2): 411-22, 2011.
Article in English | MEDLINE | ID: mdl-21658315

ABSTRACT

In the present work the effects of a new low frequency, high intensity ultrasound technology on human adipose tissue ex vivo were studied. In particular, we investigated the effects of both external and surgical ultrasound-irradiation (10 min) by evaluating, other than sample weight loss and fat release, also histological architecture alteration as well apoptosis induction. The influence of saline buffer tissue-infiltration on the effects of ultrasound irradiation was also examined. The results suggest that, in our experimental conditions, both transcutaneous and surgical ultrasound exposure caused a significant weight loss and fat release. This effect was more relevant when the ultrasound intensity was set at 100 % (~2.5 W/cm², for external device; ~19-21 W/cm2, for surgical device) compared to 70 % (~1.8 W/cm² for external device; ~13-14 W/cm2 for surgical device). Of note, the effectiveness of ultrasound was much higher when the tissue samples were previously infiltrated with saline buffer, in accordance with the knowledge that ultrasonic waves in aqueous solution better propagate with a consequently more efficient cavitation process. Moreover, the overall effects of ultrasound irradiation did not appear immediately after treatment but persisted over time, being significantly more relevant at 18 h from the end of ultrasound irradiation. Evaluation of histological characteristics of ultrasound-irradiated samples showed a clear alteration of adipose tissue architecture as well a prominent destruction of collagen fibers which were dependent on ultrasound intensity and most relevant in saline buffer-infiltrated samples. The structural changes of collagen bundles present between the lobules of fat cells were confirmed through scanning electron microscopy (SEM) which clearly demonstrated how ultrasound exposure induced a drastic reduction in the compactness of the adipose connective tissue and an irregular arrangement of the fibers with a consequent alteration in the spatial architecture. The analysis of the composition of lipids in the fat released from adipose tissue after ultrasound treatment with surgical device showed, in agreement with the level of adipocyte damage, a significant increase mainly of triglycerides and cholesterol. Finally, ultrasound exposure had been shown to induce apoptosis as shown by the appearance DNA fragmentation. Accordingly, ultrasound treatment led to down-modulation of procaspase-9 expression and an increased level of caspase-3 active form.


Subject(s)
Adipocytes/radiation effects , Adipose Tissue/radiation effects , Ultrasonic Therapy , Adipocytes/metabolism , Adipocytes/ultrastructure , Adipose Tissue/metabolism , Adipose Tissue/ultrastructure , Adult , Analysis of Variance , Apoptosis/radiation effects , Caspase 3/metabolism , Caspase 9/metabolism , Collagen/radiation effects , Collagen/ultrastructure , Female , Humans , In Vitro Techniques , Lipolysis/radiation effects , Microscopy, Electron, Scanning , Middle Aged , Skin/radiation effects , Skin/ultrastructure , Time Factors
15.
J Cell Physiol ; 226(8): 2170-80, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21520069

ABSTRACT

Neuroblastomas are pediatric tumors originating from neuroblasts in the developing peripheral nervous system. The neurotrophin brain-derived neurotrophic factor (BDNF) is a key regulator of survival and differentiation of specific neuronal populations in the central and peripheral nervous system. Patients whose neuroblastoma tumors express high levels of BDNF and TrkB have an unfavorable prognosis. We have previously reported on the neuronal differentiating activity of peroxisome proliferator-activated receptors (PPAR)ß/δ natural and synthetic ligands by modulating BDNF/TrkB pathway, suggesting their potential use as new therapeutic strategies for neuroblastoma. The validation of new therapeutic agents implies the understanding of their mechanisms of action. Herein, we report the effects of activated-PPARß/δ on signal transduction pathways known to be involved in neuronal differentiation, such as ERK1,2 and BDNF pathways. The results obtained, using also PPARß/δ silencing, indicating a neuronal differentiating effect PPARß/δ-dependent through BDNF-P75-ERK1,2 pathways, further support a role for PPARß/δ in neuronal differentiation and pointing towards PPARß/δ as a modulator of pathways crucial for neuronal differentiation. These findings open new perspectives in the formulation of potential therapeutic approaches to be used as adjuvant treatment with the standard therapies.


Subject(s)
Neurogenesis/physiology , PPAR delta/metabolism , PPAR-beta/metabolism , Signal Transduction/physiology , Brain-Derived Neurotrophic Factor/metabolism , Brain-Derived Neurotrophic Factor/physiology , Cell Line, Tumor , Gene Silencing/physiology , Humans , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 1/physiology , Mitogen-Activated Protein Kinase 3/metabolism , Mitogen-Activated Protein Kinase 3/physiology , PPAR delta/genetics , PPAR delta/physiology , PPAR-beta/genetics , PPAR-beta/physiology
16.
Int J Immunopathol Pharmacol ; 23(1): 235-46, 2010.
Article in English | MEDLINE | ID: mdl-20378009

ABSTRACT

Gliomas are histologically graded by cellularity, cytological atypia, necrosis, mitotic figures, and vascular proliferation, features associated with biologically aggressive behaviour. However, abundant evidence suggests the presence of unrecognized, clinically relevant subclasses of the diffuse gliomas, both in respect to their underlying molecular phenotype and their clinical response to therapy. It is well-known that patient prognosis and therapeutic decisions rely on accurate pathological grading. Recently, it was reported that human gliomas accumulate lipid droplets during progression, suggesting a lipid metabolism impairment. Considering the crucial role of peroxisomes in lipid metabolism, in the present work we studied the expression profiles of proteins either exclusively localized to peroxisomes, such as peroxin14 (PEX14), peroxisomal membrane protein 70Kda (PMP70), acyl-CoA oxidase, thiolase, or partially associated to peroxisomes such as Hydroxymethylglutaryl-CoA reductase (HMGCoA-red) and peroxisomal-related proteins, namely PPARalpha, in human glioma specimens at different grades of malignancy. Moreover, Nile red staining of lipid droplets, thin layer chromatography (TLC) and proton nuclear magnetic resonance spectroscopy (NMR) were carried out in order to correlate the biochemical results with the lipid content of tumor tissues. The results obtained indicate that correlating the malignancy grade with the expression of peroxisomal genes and proteins, may constitute a sensitive tool to highlight possible subtypes not recognized by the classical histological techniques.


Subject(s)
Glioma/metabolism , Lipid Metabolism , Peroxisomes/chemistry , ATP-Binding Cassette Transporters/analysis , Acyl-CoA Oxidase/analysis , Blotting, Western , Glioma/chemistry , Humans , Immunohistochemistry , Magnetic Resonance Spectroscopy , Membrane Proteins/analysis , Polymerase Chain Reaction , Repressor Proteins/analysis
17.
Curr Alzheimer Res ; 6(3): 238-51, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19519305

ABSTRACT

The central role of peroxisomes in ROS and lipid metabolism and their importance in brain functioning are well established. The aim of this work was to study the modulation of peroxisomal and peroxisome-related proteins in cortical neurons in vitro challenged with chronic or acute Abeta treatment, in order to investigate whether peroxisomes represent one of the cellular target of Abeta in these cells. The expression of peroxisomal (PMP70, catalase, acyl-CoA oxidase and thiolase), peroxisome-related (PPARalpha, insulin-degrading enzyme) and anti-oxidant (SOD1, SOD2, GSTP1) proteins was studied. The results obtained, demonstrating an early upregulation of the peroxisomal proteins during the chronic challenge, followed by their dramatic impairment after acute challenge, suggest that peroxisomes represent one of the first line of defence against Abeta-mediated oxidative injury. Our results support the notion that substances able to activate PPARalpha and/or to induce peroxisomal proliferation may constitute a novel preventive and/or therapeutic tool against neurodegenerative diseases.


Subject(s)
Amyloid beta-Peptides/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Neurons/drug effects , Peptide Fragments/pharmacology , Peroxidases/metabolism , Superoxide Dismutase/metabolism , Animals , Apoptosis/drug effects , Benzothiazoles , Cell Survival/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Embryo, Mammalian , Glutathione S-Transferase pi/genetics , Glutathione S-Transferase pi/metabolism , Indoles , Insulysin/genetics , Insulysin/metabolism , Nerve Tissue Proteins/metabolism , PPAR alpha/genetics , PPAR alpha/metabolism , Peroxidases/genetics , Rats , Reactive Oxygen Species/metabolism , Superoxide Dismutase/classification , Superoxide Dismutase/genetics , Tetrazolium Salts , Thiazoles/metabolism , Time Factors
18.
Biochim Biophys Acta ; 1778(12): 2749-56, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18762164

ABSTRACT

Phospholipid and non-phospholipid vesicles are extensively studied as drug delivery systems to modify pharmacokinetics of drugs and to improve their action in target cells. It is believed that the major barrier to efficient drug delivery is entrapment of drugs in the endosomal compartment, since this eventually leads to its degradation in lysosomes. For these reasons, the knowledge of internalization pathway plays a fundamental role in optimizing drug targeting. The aim of this work is to characterize pH-sensitive Tween 20 vesicles, their interaction with macrophage-like cells and their comparison with pH-sensitive liposomes. The effect of different amounts of cholesteryl hemissucinate on surfactant vesicle formation and pH-sensitivity was studied. To evaluate the initial mode of internalization in Raw 264.7 and the intracellular fate of neutral and pH-sensitive formulations, flow cytometry in presence and in absence of selected inhibitors and fluorescence microscopy in absence and presence of specific fluorescent endocytotic markers were used. The obtained results showed that the surfactant vesicle pH-sensitivity was about two or three fold higher than that obtained with pH-sensitive liposomes in the presence of serum in vitro. The uptake mechanism of surfactant vesicles, after incubation with macrophage-like cells, is comparable to that of liposomes (clathrin-mediated endocytosis).


Subject(s)
Endocytosis/physiology , Macrophages/metabolism , Phospholipids/pharmacokinetics , Polysorbates/pharmacokinetics , Surface-Active Agents/pharmacokinetics , Animals , Biological Transport/drug effects , Biophysical Phenomena , Cell Line , Cytoplasmic Vesicles/chemistry , Cytoplasmic Vesicles/metabolism , Endocytosis/drug effects , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Hydrogen-Ion Concentration , Liposomes/chemistry , Liposomes/metabolism , Liposomes/pharmacokinetics , Mice , Microscopy, Fluorescence , Phospholipids/chemistry , Phospholipids/metabolism , Polysorbates/metabolism , Polysorbates/pharmacology , Surface-Active Agents/metabolism , Surface-Active Agents/pharmacology
19.
J Cell Physiol ; 217(1): 93-102, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18446822

ABSTRACT

Gliomas are the most commonly diagnosed malignant brain primary tumors. Prognosis of patients with high-grade gliomas is poor and scarcely affected by radiotherapy and chemotherapy. Several studies have reported antiproliferative and/or differentiating activities of some lipophylic molecules on glioblastoma cells. Some of these activities in cell signaling are mediated by a class of transcriptional factors referred to as peroxisome proliferator-activated receptors (PPARs). PPARgamma has been identified in transformed neural cells of human origin and it has been demonstrated that PPARgamma agonists decrease cell proliferation, stimulate apoptosis and induce morphological changes and expression of markers typical of a more differentiated phenotype in glioblastoma and astrocytoma cell lines. These findings arise from studies mainly performed on long-term cultured transformed cell lines. Such experimental models do not exactly reproduce the in vivo environment since long-term culture often results in the accumulation of further molecular alterations in the cells. To be as close as possible to the in vivo condition, in the present work we investigated the effects of PPARgamma natural and synthetic ligands on the biomolecular features of primary cultures of human glioblastoma cells derived from surgical specimens. We provide evidence that PPARgamma agonists may interfere with glioblastoma growth and malignancy and might be taken in account as novel antitumoral drugs.


Subject(s)
Anilides/pharmacology , Brain Neoplasms/metabolism , Glioblastoma/metabolism , Linoleic Acids, Conjugated/pharmacology , PPAR gamma/agonists , Apoptosis/drug effects , Blotting, Western , Cell Adhesion/drug effects , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Fluorescent Antibody Technique , Humans , Neovascularization, Pathologic/metabolism , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide Synthase Type II/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Vascular Endothelial Growth Factor A/biosynthesis , Vascular Endothelial Growth Factor A/drug effects
20.
PPAR Res ; 2007: 48242, 2007.
Article in English | MEDLINE | ID: mdl-17710110

ABSTRACT

PPAR isotypes are involved in the regulation of cell proliferation, death, and differentiation, with different roles and mechanisms depending on the specific isotype and ligand and on the differentiated, undifferentiated, or transformed status of the cell. Differentiation stimuli are integrated by key transcription factors which regulate specific sets of specialized genes to allow proliferative cells to exit the cell cycle and acquire specialized functions. The main differentiation programs known to be controlled by PPARs both during development and in the adult are placental differentiation, adipogenesis, osteoblast differentiation, skin differentiation, and gut differentiation. PPARs may also be involved in the differentiation of macrophages, brain, and breast. However, their functions in this cell type and organs still awaits further elucidation. PPARs may be involved in cell proliferation and differentiation processes of neural stem cells (NSC). To this aim, in this work the expression of the three PPAR isotypes and RXRs in NSC has been investigated.

SELECTION OF CITATIONS
SEARCH DETAIL
...